|Basic InformationMore InformationLatest News|Environmental Enrichment Reduces Autism Symptoms1 in 5 U.S. Kids Has a Mental Health Disorder: CDCKids With Autism May Perceive Movement More QuicklyMore Kids Diagnosed With Mental Health Disabilities, Study FindsBrain Differences Seen in Kids With Conduct ProblemsGirls With Autism May Need Different Treatments Than BoysNewborn's Placenta May Predict Autism Risk, Study SuggestsThe 'Learning Curve' of Living With Asperger'sGuideline Changes Have Asperger's Community on EdgeAge of Autism Diagnosis May Depend on Symptoms: StudyChanges to Psychiatry's 'Bible' Could Widen Definition of ADHDKids With Autism May Be Less Likely to Imitate 'Silly' BehaviorOne in 10 U.S. Kids Diagnosed With ADHD: ReportAnother Study Sees No Vaccine-Autism LinkOne in 50 School-Aged Children in U.S. Has Autism: CDCBrain Circuitry Yields Clue to Autism, Researchers SayDon't Give ADHD Meds to Undiagnosed Kids, Experts UrgeMost Kids With Autism Overcome Language Delays, Study FindsBrain Connections Differ in Children With AutismCan Therapy Dogs Help Kids With Autism?Researchers Detect an Anti-Autism Advantage in FemalesADHD Symptoms Stable From Preschool Diagnosis to Year SixDon't Overlook Eating Issues Tied to Autism, Study WarnsSome Dietary Interventions Improve ADHD SymptomsNon-Drug ADHD Treatments Don't Pan Out in StudyMore U.S. Children Diagnosed With ADHDFor Some Children, Autism Symptoms May Fade With AgeResearchers Link 25 New Gene Variants to AutismBullying Harms Kids With Autism, Parents SayExposure to Traffic-Related Air Pollution Linked to AutismIs the Mental Health System Failing Troubled Kids?Asperger's, Autism Not Linked to Violence: ExpertsGene Study Uncovers More Autism CluesKids With Autism Common Users of ERs, Study SaysYoungest Kids in Class May Be More Likely to Get ADHD DiagnosisADHD Drugs Didn't Raise Heart Risks for Kids, Study FindsPlay-Focused Program Might Help Kids With AutismAutism Tough to Spot Before 6 Months of Age, Study SuggestsSingle Bout of Exercise Benefits Children With ADHDKids With Autism Find It Hard to Describe Poor Behavior, Study FindsNearly Half of Children With Autism Wander From Safety: SurveyNew Autism Criteria Will Have Minor Impact: StudyPsychiatric Disorders Often Persist in Juvenile OffendersResearch Lacking on Drugs for Older Children With Autism, Study FindsDrug Shows Promise Against Fragile X Syndrome, Possibly AutismAntipsychotic Use Up Among U.S. Medicaid-Enrolled YouthAlmost Half of U.S. Kids With Autism Have Been BulliedMore Kids Taking Antipsychotics for ADHD: StudyCortical Surface Area Maturation Delayed in ADHDPets May Help Kids With Autism Develop Social SkillsQuestions and AnswersLinksBook Reviews
Animal Study: Long-Term Ritalin Doesn't Impact Growth
Updated: Jul 20th 2012
FRIDAY, July 20 (HealthDay News) -- Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study published online July 18 in Neuropsychopharmacology.
Kathryn E. Gill, from the Wake Forest School of Medicine in Winston Salem, N.C., and colleagues treated 16 juvenile male rhesus monkeys (about 30 months old) daily with placebo or a sustained-release formulation of methylphenidate for a year, followed by a washout period of three to five months. The animals were then given the opportunity to intravenously administer cocaine over several months.
The researchers found that chronic methylphenidate treatment had no effect on weight gain or other measures of growth. Imaging studies showed no difference on the binding availability of D2/D3 receptors and dopamine transporters, although, after washout, D2/D3 receptor availability did not continue to decline at the same rate as controls. Chronic methylphenidate treatment had no effect on the propensity to acquire cocaine, overall response rates, or cocaine intake.
"In an animal model that closely mimics human development, chronic treatment with therapeutic doses of sustained-release methylphenidate did not have a significant influence on the regulation of dopamine transporters or D2/D3 receptors, or on standard measures of growth," Gill and colleagues conclude. "Furthermore, this treatment regimen and subsequent drug washout did not have an impact on vulnerability to cocaine abuse."
One author disclosed financial ties to pharmaceutical companies, including UCB Inc., which provided the methylphenidate.
Full Text (subscription or payment may be required)
This article: Copyright © 2012 HealthDay. All rights reserved.